The COVID-19 pandemic had a significant impact on various aspects of public health. The imposed restrictions forced people to spend more time at home, which may have resulted in a decline in physical activity and a deterioration of diet quality in affected populations including patients with hypertension [1,2]. Due to limited access to medical care, some patients did not attend regular medical follow-up visits [3], which led to delays in diagnosing diseases related to unhealthy lifestyles [4]. Moreover, difficulties in monitoring patients with already diagnosed cardiovascular diseases (CVD), including hypertension, was often associated with the inability to modify their treatment.
